GRIN2D: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 13:20, 17 March 2025
GRIN2D is a gene that encodes a subunit of the N-methyl-D-aspartate (NMDA) receptor, a type of ionotropic glutamate receptor in the human body. The NMDA receptor is crucial for controlling synaptic plasticity and memory function.
Function[edit]
The GRIN2D gene is part of the glutamate receptor family of genes, which play a key role in the central nervous system's excitatory synaptic transmission. The protein encoded by the GRIN2D gene forms a heteromeric complex with GRIN1 to create an NMDA receptor. This receptor is a voltage-dependent calcium channel that is permeable to cations and is activated by the neurotransmitter glutamate and the co-agonist glycine.
Clinical Significance[edit]
Mutations in the GRIN2D gene have been associated with various neurological disorders. These include epileptic encephalopathy, a type of epilepsy characterized by frequent seizures and cognitive impairment. Other disorders linked to GRIN2D mutations include intellectual disability and autism spectrum disorder.
Research[edit]
Research into the GRIN2D gene and its associated proteins is ongoing. Understanding the function and structure of the NMDA receptor could lead to new treatments for neurological disorders.
See Also[edit]
- NMDA receptor
- Glutamate receptor
- Epileptic encephalopathy
- Intellectual disability
- Autism spectrum disorder
References[edit]
<references />
